Skip to content

AtriCure ATRC Accrued Expenses

Accrued Expenses at other companies

Medtronic logo
MedtronicMDT
$3.63B-1.3%
Pulse Biosciences, Inc. logo
Pulse Biosciences, Inc.PLSE
$5.41M+35.7%
ITG
Integer HoldingsITGR
$83.23M-2.8%
Avanos Medical logo
Avanos MedicalAVNS
$57.6M-19.3%

Other financials

Income statement

See full
Revenue$141.2M+14.3%
Gross profit$109.3M+18.0%
Operating income$526.0K+109%
Net income$108.0K+102%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$146.2M+46.3%
Total debt$76.2M-3.1%
Total equity$491.7M+8.2%
Total assets$644.0M+8.8%

Cash flow

See full
Operating cash flow-$4.0M+63.8%
CapEx$3.9M+76.6%
Free cash flow-$7.8M+40.6%

Valuation

See full
Market cap$1.43B-9.9%
Enterprise value$1.36B-13.1%
P/S2.6×-0.7×

Profitability

See full
Gross margin75.6%+0.8pp
Operating margin-5.1%-1.3pp
Net margin-5.6%-1.5pp
FCF margin9.7%

Returns & leverage

See full
Return on equity-6.1%-1.3pp
Debt / equity0.2×0.0×
Current ratio4.3×+0.2×

Where this comes from

Reported directly by AtriCure in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: AtriCure’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AtriCure's accrued expenses?
AtriCure (ATRC) reported accrued expenses of $32.25M in Q1 2026.
How has AtriCure's accrued expenses changed year-over-year?
AtriCure's accrued expenses increased by 20.0% year-over-year, from $26.88M to $32.25M.
What is the long-term trend for AtriCure's accrued expenses?
Over 5 years (2020 to 2025), AtriCure's accrued expenses has grown at a 40.9% compound annual growth rate (CAGR), from $8.42M to $46.76M.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.